Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: MMP Portfolio™ Prevails After Multiple Reexams

Very nice I like these parts a lot.

“This remarkable story demonstrates,” said Mac Leckrone, President of Alliacense, “that the reexam delay tactic routinely encouraged by lawyers defies business sense, since it usually backfires by strengthening the very patents under attack.”

Combined with favorable “Markman” Rulings in the Eastern District of Texas in 2007, and the steady addition of over 60 licensees since the launch of the Licensing Program in 2005, the MMP Portfoliocontinues its phenomenal ascendance as one of the most important patent portfolios in the history of electronics.

Mike Davis, Senior Vice President of Licensing, added, “These developments obviously diminish any uncertainties associated with purchasing the required MMP Portfolio license, and will thus have a direct impact on the market price going forward.” Davis also confirmed that progressively higher royalty rates remain a basic principle of the MMP Portfolio Licensing Program.

Much work to be done but much of the risk holding back investors has been removed imo. Nice to see the 20's again. Let it role.

Long and stronger!

Steve

Share
New Message
Please login to post a reply